TMO
Thermo Fisher Scientific Inc
Price:  
423.55 
USD
Volume:  
2,492,375.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TMO WACC - Weighted Average Cost of Capital

The WACC of Thermo Fisher Scientific Inc (TMO) is 8.2%.

The Cost of Equity of Thermo Fisher Scientific Inc (TMO) is 8.95%.
The Cost of Debt of Thermo Fisher Scientific Inc (TMO) is 5.00%.

Range Selected
Cost of equity 7.80% - 10.10% 8.95%
Tax rate 9.20% - 10.30% 9.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 9.2% 8.2%
WACC

TMO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.85 0.94
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.10%
Tax rate 9.20% 10.30%
Debt/Equity ratio 0.2 0.2
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 9.2%
Selected WACC 8.2%

TMO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for TMO:

cost_of_equity (8.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.85) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.